Serious infections in British patients with systemic lupus erythematosus: Hospitalisations and mortality

Lupus

Volumn 18, Issue 8, 2009, Pages 682-689

  Goldblatt, Fiona ^a   Chambers, S ^a   Rahman, A ^a   Isenberg, D A ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

British; Infection; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; SULFAMETHOXYPYRIDAZINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; DRUG USE; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; INFECTION; INFECTION COMPLICATION; INFECTION RISK; INFECTIOUS PNEUMONIA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHRITIS; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; PYELONEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; BACTERIAL INFECTIONS; FEMALE; GREAT BRITAIN; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREDNISOLONE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 67049167424     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308101019     Document Type: Article

References (21)

1. Peschken C, Esdaile J. Systemic lupus erythematosus in North American Indians: A population based study. J Rheumatol 2000; 27: 1884-1891.
2. Fessler B. Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 2002; 16: 281-291.
3. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus and infection: A controlled and prospective study including as epidemiological group. Q J Med 1985; 218: 271-287.
4. Rubin L, Urowitz M, Gladman D. Mortality in systemic lupus erythematosus: The bimodal pattern revisited. Q J Med 1985; 55: 87-98.
5. Cervera R, Khamashta M, Font J. Morbidity and mortality in systemic lupus erythematosus during a 5-year period: A multicenter prospective study of 1,000 patients. Medicine 1999; 78: 167-175.
6. Iliopoulos A, Tsokos G. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum 1996; 25: 318-336.
7. Noel V, Lortholary O, Casassus P. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 2001; 60: 1141-1144.
8. Gladman D, Hussain F, Ibanez D, Urowitz M. The nature and outcome of infection in systemic lupus erythematosus. Lupus 2002; 11: 234-239.
9. Turner M. Mannose-binding lectin (MBL) in health and disease. Immunobiology 1998; 199: 327-339.
10. Jacobsen S. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol 1998; 17: 478-484.
11. Moss K, Ioannou Y, Sultan S, Haq I, Isenberg D. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 2002; 61: 409-413.
12. Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
13. Hay E, Bacon P, Gordon C. The BILAG index: A reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993; 6: 447-458.
14. Gladman D, Ginzler E, Goldsmith C. The development and initial validation of the Systemic Lupus International Collaborating Clinics/ American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
15. Kim W, Min J, Lee S, Park SH, Cho CS, Kim HY. Causes of death in Korean patients with systemic lupus erythematosus: A single center retrospective study. Clin Exp Rheumatol 1999; 17: 539-545.
16. Jacobsen S, Petersen J, Ullman S. Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol 1999; 28: 75-80.
17. Al-Rayes H, Al-Swailem R, Arfin M, Sobki S, Rizvi S, Tariq M. Lupus Around the World: Systemic lupus erytheAatosus and infections: a retrospective study in Saudis. Lupus 2007; 16: 755-763.
18. Petri M, Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: A prospective study of the Hopkins Lupus Cohort. J Rheumatol 1992; 19: 1559-1565.
19. Duffy K, Duffy C, Gladman D. Infection and disease activity in systemic lupus erythematosus: A review of hospitalized patients. J Rheumatol 1991; 18: 1180-1184.
20. Ortmann R, Klippel J. Update on cyclophosphamide for systemic lupus erythematosus. Rheum Dis Clin North Am 2000; 26: 363-375.
21. O'Neill S, Isenberg D. Immunizing patients with systemic lupus erythematosus: A review of effectiveness and safety. Lupus 2006; 15: 778-783.